GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zim Laboratories Ltd (BOM:541400) » Definitions » Short-Term Debt

Zim Laboratories (BOM:541400) Short-Term Debt : ₹708 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Zim Laboratories Short-Term Debt?

Zim Laboratories's Short-Term Debt for the quarter that ended in Mar. 2024 was ₹708 Mil.

Zim Laboratories's quarterly Short-Term Debt declined from Sep. 2023 (₹222 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹708 Mil).

Zim Laboratories's annual Short-Term Debt increased from Mar. 2022 (₹323 Mil) to Mar. 2023 (₹348 Mil) and increased from Mar. 2023 (₹348 Mil) to Mar. 2024 (₹708 Mil).


Zim Laboratories Short-Term Debt Historical Data

The historical data trend for Zim Laboratories's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zim Laboratories Short-Term Debt Chart

Zim Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 624.30 592.41 322.61 347.86 707.52

Zim Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 347.86 - 222.30 - 707.52

Zim Laboratories Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Zim Laboratories Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Zim Laboratories's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Zim Laboratories (BOM:541400) Business Description

Traded in Other Exchanges
Address
Nelson Square, Chhindwara Road, Sadoday Gyan, Ground Floor, Opposite NADT, Nagpur, MH, IND, 440 013
Zim Laboratories Ltd is a pharmaceutical company. It is mainly engaged in the manufacturing of formulation drugs and pre-formulation ingredients. Geographically, the group has a business presence in India and other countries, of which key revenue is derived from Outside India. The products offered by the company are Ondansetron, Tadalafil, Vitamin D3, Levocetirizine, Methylcobalamin, and others. The majority of its revenue gets derived from the sale of pharmaceutical goods.

Zim Laboratories (BOM:541400) Headlines

No Headlines